Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.
Tricco, Andrea C
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review. [electronic resource] - BMC pharmacology & toxicology Jan 2015 - 1 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
2050-6511
10.1186/2050-6511-16-1 doi
Antiemetics--administration & dosage
Antineoplastic Agents--administration & dosage
Arrhythmias, Cardiac--chemically induced
Drug Therapy, Combination--adverse effects
Electrocardiography--drug effects
Humans
Indoles--adverse effects
Isoquinolines--administration & dosage
Ondansetron--administration & dosage
Palonosetron
Quinolizines--adverse effects
Quinuclidines--administration & dosage
Serotonin 5-HT3 Receptor Antagonists--administration & dosage
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review. [electronic resource] - BMC pharmacology & toxicology Jan 2015 - 1 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
2050-6511
10.1186/2050-6511-16-1 doi
Antiemetics--administration & dosage
Antineoplastic Agents--administration & dosage
Arrhythmias, Cardiac--chemically induced
Drug Therapy, Combination--adverse effects
Electrocardiography--drug effects
Humans
Indoles--adverse effects
Isoquinolines--administration & dosage
Ondansetron--administration & dosage
Palonosetron
Quinolizines--adverse effects
Quinuclidines--administration & dosage
Serotonin 5-HT3 Receptor Antagonists--administration & dosage